[
    [
        {
            "time": "2021-01-12",
            "original_text": "Eli Lilly Has Good News About Its Alzheimer’s Drug. Here’s What It Means for Biogen.",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Alzheimer’s Drug",
                    "Good News",
                    "Positive Results"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly Has Good News About Its Alzheimer’s Drug. Here’s What It Means for Biogen.",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-01-12",
            "original_text": "Lilly's (LLY) Alzheimer's Drug Promising in Mid-Stage Study",
            "features": {
                "keywords": [
                    "Lilly",
                    "Alzheimer's Drug",
                    "Promising",
                    "Mid-Stage Study"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly's (LLY) Alzheimer's Drug Promising in Mid-Stage Study",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-01-12",
            "original_text": "Company News for Jan 12, 2021",
            "features": {
                "keywords": [
                    "Company News",
                    "Jan 12"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Company News for Jan 12, 2021",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 2,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 3,
                "Source_Recency": 2
            }
        },
        {
            "time": "2021-01-12",
            "original_text": "Eli Lilly Jumps After Alzheimer’s Drug Shows Positive Results",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Jumps",
                    "Alzheimer’s Drug",
                    "Positive Results"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Jumps After Alzheimer’s Drug Shows Positive Results",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]